Drugmakers Delay In-Demand Medicines to Evade Biden’s New Pricing Rules

Published on 22 Dec 2023 on Bloomberg

Drugmakers are slow-walking products to market to get around President Joe Biden’s plan to lower...

Read the rest of the article

Start tracking your investments with Statfolio

The demand for nucleic acid-based therapeutics has soared in recent years due to their effectiven...

Digital Journal 19 Apr 2024

One stock that might be an intriguing choice for investors right now is Alnylam Pharmaceuticals, ...

Zacks via Yahoo Finance 8 Apr 2024

Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standar...

Investing.com 7 Apr 2024

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2023 Earnings Call Transcript February 15, 2024 Al...

Insider Monkey via Yahoo Finance 16 Feb 2024

Alnylam Pharmaceuticals Inc. saw its stock price sink to its lowest point in the last year after ...

The Business Journals 16 Feb 2024

Alnylam Pharmaceuticals ALNY reported a loss of $1.10 per share in the fourth quarter of 2023, na...

Zacks via Yahoo Finance 16 Feb 2024

Revenue Growth: Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) reported a 39% increase in annual globa...

GuruFocus.com via Yahoo Finance 15 Feb 2024

Strengths: Pioneering RNAi therapeutics with a robust product portfolio and strategic collaborati...

GuruFocus.com via Yahoo Finance 15 Feb 2024

The fourth-quarter 2023 reporting cycle of the Medical sector picked up pace in the last two week...

Zacks via Yahoo Finance 14 Feb 2024

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY), a biopharmaceutical company, focuses on the discovery,...

GuruFocus.com via Yahoo Finance 6 Feb 2024